Astrana Health (NASDAQ:ASTH) Updates FY24 Earnings Guidance

Astrana Health (NASDAQ:ASTH) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.28 to $1.52 for the period, compared to the consensus estimate of $1.60. The company issued revenue guidance of $1.65 billion to $1.85 billion, compared to the consensus revenue estimate of $1.76 billion.

Astrana Health Trading Up 0.4 %

Astrana Health stock traded up $0.16 during mid-day trading on Wednesday, hitting $38.09. The stock had a trading volume of 158,668 shares, compared to its average volume of 154,030. The firm’s 50-day moving average is $40.24. The firm has a market cap of $2.13 billion, a PE ratio of 28.86, a PEG ratio of 1.20 and a beta of 1.12. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.11 and a quick ratio of 2.11. Astrana Health has a 12 month low of $28.86 and a 12 month high of $45.71.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.01). Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The company had revenue of $404.36 million for the quarter, compared to analyst estimates of $413.84 million. During the same quarter last year, the business earned $0.42 earnings per share. The company’s revenue was up 19.9% on a year-over-year basis. Sell-side analysts expect that Astrana Health will post 1.65 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Stifel Nicolaus lowered their price objective on shares of Astrana Health from $50.00 to $45.00 and set a buy rating for the company in a research note on Wednesday. Jefferies Financial Group started coverage on shares of Astrana Health in a research note on Monday, February 26th. They set a buy rating and a $50.00 price target on the stock. Finally, Truist Financial raised their price target on shares of Astrana Health from $41.00 to $44.00 and gave the stock a hold rating in a report on Friday, March 1st.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.